Wilber Wei-Poh Su, MD
Cardiovascular Disease (Cardiology) · Phoenix
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Banner - University Physician Specialists LLC · 343 clinicians in this group
Looking this up.
Hospitals listed: Banner - University Medical Center Phoenix. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Su’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C150496 · Current
Licensed to practise in California · since 2017 · expires 2026-11-30 · Tufts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Banner - University Medical Center PhoenixPhoenix, AZAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Banner Health, which runs 33 hospitals in 6 statesPatients rate it 2 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.3 (1.08 to 1.53), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.98 (2.74 to 5.22) · 1,159 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 14.75 (10.66 to 18.85) · 1,189 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.096, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.611, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.246, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.351, Oct 2024 – Sep 2025
See every measure and the patient survey for Banner - University Medical Center Phoenix
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 3 the same, 1 worse of 7 measures. Readmissions: 1 better, 7 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.3 (1.08 to 1.53) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.98 (2.74 to 5.22) · 1,159 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 14.75 (10.66 to 18.85) · 1,189 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.096 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.611 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.246 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.351 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.35 (0.5 to 2.2) · 1,697 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 183.2 (149.21 to 217.19) · 201 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.2 · 238 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 268 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 623 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,853 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.41) · 6,090 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.45) · 6,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.96 (1.32 to 4.6) · 2,728 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.2 (2 to 4.4) · 2,515 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.09 (4.27 to 9.91) · 1,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.01 (0.62 to 3.39) · 587 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.63 (0.16 to 1.11) · 5,710 cases | No different | Jul 2022 – Jun 2024 |
| SSI - Abdominal HysterectomyInfections | 0.518 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.042 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 237 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 790 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.7 · 290 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 48 · 270 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 730 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7 (4.9 to 9.9) · 154 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (7.4 to 13.3) · 154 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11.3 · 128 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 227 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.8 to 17.1) · 567 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.6) · 405 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,209 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$145,087
Medicare paid this office $145,087 for 377 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 76 | $54,975 | $714 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 56 | $16,376 | $231 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 48 | $11,336 | $231 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $10,108 | $632 |
| Return visit (30+ min) | 57 | $4,076 | $64 |
See all 21 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 76 | $54,975 | $714 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 56 | $16,376 | $231 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 48 | $11,336 | $231 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $10,108 | $632 |
| Return visit (30+ min) | 57 | $4,076 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,613 | $90 |
| New patient visit (45+ min) | 35 | $3,544 | $101 |
| Return visit (30+ min) | 44 | $3,248 | $68 |
| New patient visit (45+ min) | 31 | $3,081 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,750 | $61 |
| Long return visit (40+ min) | 24 | $2,491 | $104 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,029 | $101 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 62 | $1,867 | $19 |
| Programming of heart rhythm stimulation after drug infusion | 34 | $1,739 | $51 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 13 | $1,646 | $127 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 38 | $1,497 | $24 |
| Long return visit (40+ min) | 13 | $1,453 | $112 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,196 | $80 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 27 | $824 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $151 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 15 | $81 | $5 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
377 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 9% · Women 43% · Also on Medicaid 7% · Health risk score 1.62. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Coronary heart disease 53% · Heart failure 45% · Chronic kidney disease 32% · Diabetes 26% · Depression 20% · Cancer 18% · COPD 18% · Stroke 17% · Dementia 8%.
The office billed $575,293, Medicare allowed $184,703 and paid $145,087; for 1,030 services of 55 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 377 | 1,030 | 75 | 1.62 | $575,293 | $145,087 |
| 2023 | 401 | 1,115 | 74 | 1.72 | $526,106 | $140,332 |
| 2022 | 380 | 1,167 | 74 | 1.50 | $510,444 | $148,246 |
| 2021 | 340 | 1,330 | 74 | 1.48 | $534,338 | $166,371 |
| 2020 | 279 | 982 | 74 | 1.67 | $395,699 | $125,336 |
| 2019 | 349 | 1,615 | 73 | 1.80 | $715,731 | $208,965 |
| 2018 | 334 | 1,795 | 73 | 1.80 | $868,058 | $250,611 |
| 2017 | 325 | 1,816 | 73 | 1.56 | $935,142 | $275,552 |
| 2016 | 277 | 1,526 | 73 | 1.61 | $608,077 | $224,462 |
| 2015 | 302 | 1,964 | 72 | 1.47 | $735,003 | $256,191 |
| 2014 | 283 | 1,786 | 72 | 1.56 | $744,129 | $261,335 |
| 2013 | 344 | 1,950 | 71 | 1.75 | $745,629 | $255,897 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 63 | $47,568 | $732 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 48 | $15,389 | $237 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 32 | $8,286 | $237 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $8,154 | $92 |
| Return visit (30+ min) | 77 | $5,067 | $63 |
| New patient visit (45+ min) | 38 | $3,275 | $86 |
| Return visit (30+ min) | 40 | $3,198 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $3,162 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $2,746 | $102 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 21 | $2,740 | $130 |
| Long return visit (40+ min) | 22 | $2,198 | $96 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 63 | $2,049 | $20 |
| New patient visit (45+ min) | 19 | $1,950 | $103 |
| Long return visit (40+ min) | 17 | $1,677 | $99 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 27 | $1,505 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 37 | $1,423 | $25 |
| External shock to heart to regulate heart beat | 11 | $926 | $84 |
| Insertion of heart rhythm monitor under skin | 11 | $744 | $68 |
| Short return visit (20+ min) | 13 | $437 | $34 |
| Programming of dual lead pacemaker system | 11 | $361 | $26 |
| Programming of dual lead pacemaker system | 11 | $348 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $121 | $6 |
2022: 24 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 67 | $59,006 | $868 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 45 | $12,500 | $240 |
| Return visit (30+ min) | 104 | $9,154 | $68 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $7,555 | $630 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 25 | $6,094 | $244 |
| New patient visit (45+ min) | 62 | $5,541 | $89 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,110 | $393 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $3,825 | $55 |
| Long return visit (40+ min) | 24 | $2,847 | $109 |
| Short return visit (20+ min) | 53 | $2,450 | $42 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 14 | $1,895 | $135 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,687 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,350 | $79 |
| Programming of heart rhythm stimulation after drug infusion | 17 | $1,294 | $76 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 43 | $1,197 | $20 |
| External shock to heart to regulate heart beat | 13 | $1,098 | $84 |
| Programming of dual lead pacemaker system | 31 | $1,081 | $27 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 27 | $1,060 | $25 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $1,019 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 141 | $992 | $6 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 30 | $964 | $16 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $626 | $42 |
| Programming of dual lead implantable defibrillator system | 11 | $581 | $41 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $169 | $10 |
2021: 25 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 57 | $50,538 | $887 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 68 | $16,477 | $235 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 38 | $14,524 | $338 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $11,281 | $664 |
| Return visit (30+ min) | 95 | $9,200 | $75 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 18 | $6,075 | $338 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 62 | $5,752 | $90 |
| New patient visit (45+ min) | 52 | $5,384 | $104 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 32 | $4,372 | $137 |
| Long return visit (40+ min) | 32 | $4,074 | $113 |
| Programming of heart rhythm stimulation after drug infusion | 35 | $3,503 | $100 |
| Telephone medical discussion with physician, 21-30 minutes | 51 | $3,185 | $58 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 29 | $1,904 | $20 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,779 | $56 |
| Short return visit (20+ min) | 43 | $1,694 | $38 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 43 | $1,573 | $22 |
| Programming of dual lead pacemaker system | 36 | $1,427 | $29 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,302 | $93 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 31 | $1,289 | $25 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,178 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 124 | $985 | $6 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $914 | $46 |
| Programming of multiple lead implantable defibrillator system | 13 | $695 | $50 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 11 | $402 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $228 | $10 |
2020: 21 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 42 | $39,267 | $913 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 50 | $12,235 | $240 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 26 | $8,896 | $342 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 21 | $7,159 | $341 |
| Programming of heart rhythm stimulation after drug infusion | 46 | $5,985 | $127 |
| Telephone medical discussion with physician, 21-30 minutes | 74 | $5,754 | $63 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 48 | $5,628 | $115 |
| Return visit (30+ min) | 58 | $3,793 | $55 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 20 | $2,792 | $140 |
| New patient visit (45+ min) | 34 | $2,759 | $81 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 39 | $1,641 | $29 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,437 | $111 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 44 | $1,390 | $25 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 22 | $1,370 | $21 |
| Long return visit (40+ min) | 19 | $1,338 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,041 | $58 |
| Short return visit (20+ min) | 32 | $1,018 | $32 |
| External shock to heart to regulate heart beat | 11 | $974 | $89 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $783 | $41 |
| Programming of dual lead pacemaker system | 19 | $594 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 92 | $573 | $5 |
2019: 31 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 56 | $50,059 | $894 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 81 | $19,284 | $235 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 50 | $18,514 | $337 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 25 | $17,364 | $668 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 73 | $8,359 | $113 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 60 | $8,341 | $137 |
| New patient visit (45+ min) | 90 | $8,113 | $90 |
| Programming of heart rhythm stimulation after drug infusion | 63 | $8,046 | $126 |
| Insertion of implantable defibrillator system | 11 | $7,978 | $725 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 19 | $6,449 | $339 |
| Return visit (30+ min) | 80 | $5,769 | $58 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $4,849 | $404 |
| Long return visit (40+ min) | 37 | $3,133 | $80 |
| Short return visit (20+ min) | 56 | $2,284 | $36 |
| Insertion of tube in left heart chamber through heart septum | 14 | $2,255 | $161 |
| External shock to heart to regulate heart beat | 24 | $2,216 | $85 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 23 | $2,186 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 225 | $1,860 | $6 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,631 | $82 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 33 | $1,596 | $19 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,586 | $99 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 39 | $1,406 | $27 |
| Programming of multiple lead implantable defibrillator system | 20 | $1,296 | $50 |
| Programming of dual lead pacemaker system | 31 | $1,120 | $29 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 33 | $945 | $22 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $873 | $73 |
| Programming of dual lead implantable defibrillator system | 14 | $871 | $46 |
| Insertion of heart rhythm monitor under skin | 12 | $781 | $65 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $503 | $28 |
| Short return visit | 22 | $429 | $20 |
| Evaluation of cardiac rhythm monitor system | 15 | $291 | $15 |
2018: 29 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 64 | $57,420 | $883 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 94 | $25,403 | $257 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 35 | $23,056 | $659 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 53 | $20,683 | $339 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 37 | $12,537 | $339 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 83 | $11,954 | $137 |
| Programming of heart rhythm stimulation after drug infusion | 89 | $11,784 | $127 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 85 | $10,232 | $114 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,608 | $401 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $5,161 | $82 |
| New patient visit (45+ min) | 54 | $5,018 | $93 |
| Short return visit (20+ min) | 104 | $4,806 | $35 |
| External shock to heart to regulate heart beat | 44 | $4,437 | $85 |
| New patient visit (60+ min) | 33 | $3,566 | $108 |
| Insertion of tube in left heart chamber through heart septum | 21 | $3,508 | $167 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 36 | $3,365 | $93 |
| Long return visit (40+ min) | 34 | $2,580 | $76 |
| Return visit (30+ min) | 42 | $2,461 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,358 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 228 | $1,772 | $6 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 29 | $1,374 | $34 |
| Programming of dual lead pacemaker system | 32 | $1,202 | $26 |
| Programming of multiple lead implantable defibrillator system | 18 | $1,099 | $46 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 24 | $1,096 | $20 |
| New patient visit (30+ min) | 20 | $964 | $48 |
| Programming of dual lead implantable defibrillator system | 15 | $905 | $41 |
| Short return visit | 41 | $779 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 17 | $411 | $23 |
| Evaluation of cardiac rhythm monitor system | 14 | $261 | $12 |
2017: 37 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 66 | $58,849 | $878 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 62 | $38,467 | $337 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 93 | $30,522 | $315 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 29 | $19,394 | $646 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 56 | $18,919 | $338 |
| Programming of heart rhythm stimulation after drug infusion | 97 | $12,767 | $126 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 88 | $10,466 | $114 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 68 | $9,604 | $137 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $5,683 | $379 |
| External shock to heart to regulate heart beat | 43 | $4,030 | $84 |
| Short return visit (20+ min) | 90 | $3,723 | $34 |
| Insertion of tube in left heart chamber through heart septum | 20 | $3,514 | $167 |
| Removal and replacement of multiple lead defibrillator | 12 | $3,483 | $290 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,592 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,303 | $100 |
| Short return visit (20+ min) | 48 | $1,924 | $38 |
| New patient visit (45+ min) | 24 | $1,892 | $79 |
| New patient visit (60+ min) | 18 | $1,758 | $98 |
| New patient visit (45+ min) | 14 | $1,428 | $102 |
| Long return visit (40+ min) | 14 | $1,398 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,194 | $54 |
| New patient visit (30+ min) | 20 | $1,173 | $59 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,159 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 147 | $1,116 | $6 |
| Return visit (30+ min) | 17 | $1,051 | $58 |
| Programming of dual lead pacemaker system | 32 | $1,035 | $27 |
| Programming of multiple lead implantable defibrillator system | 16 | $1,030 | $49 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $962 | $44 |
| Short return visit | 50 | $953 | $19 |
| New patient visit (30+ min) | 18 | $818 | $45 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $748 | $53 |
| Return visit (30+ min) | 13 | $744 | $53 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $741 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 85 | $602 | $7 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 12 | $487 | $21 |
| Programming of dual lead pacemaker system | 13 | $426 | $30 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 13 | $294 | $20 |
2016: 28 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 58 | $52,373 | $903 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 54 | $29,540 | $340 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 69 | $22,582 | $318 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 58 | $19,691 | $340 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $10,130 | $675 |
| Programming of heart rhythm stimulation after drug infusion | 72 | $9,386 | $127 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 71 | $8,161 | $113 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 59 | $8,053 | $136 |
| Return visit (30+ min) | 69 | $5,107 | $57 |
| New patient visit (60+ min) | 33 | $4,363 | $132 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,272 | $388 |
| External shock to heart to regulate heart beat | 39 | $4,178 | $97 |
| Short return visit (20+ min) | 77 | $3,266 | $37 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 39 | $2,517 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,493 | $57 |
| Insertion of tube in left heart chamber through heart septum | 11 | $1,842 | $167 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 180 | $1,597 | $6 |
| Programming of multiple lead implantable defibrillator system | 25 | $1,515 | $49 |
| New patient visit (30+ min) | 23 | $1,300 | $57 |
| Long return visit (40+ min) | 12 | $1,223 | $87 |
| Hospital observation care on day of discharge | 20 | $1,145 | $57 |
| Programming of dual lead pacemaker system | 24 | $1,084 | $29 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $754 | $20 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $619 | $31 |
| Short return visit | 25 | $515 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 20 | $506 | $24 |
| Evaluation of cardiac rhythm monitor system | 13 | $352 | $17 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 13 | $218 | $16 |
2015: 31 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 69 | $61,817 | $883 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 75 | $23,718 | $308 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 52 | $21,641 | $333 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 59 | $19,750 | $329 |
| Insertion of implantable defibrillator system | 25 | $17,722 | $709 |
| Return visit (30+ min) | 145 | $12,503 | $53 |
| Programming of heart rhythm stimulation after drug infusion | 79 | $10,314 | $127 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 76 | $8,873 | $114 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 58 | $7,878 | $136 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 17 | $6,092 | $358 |
| Short return visit (20+ min) | 82 | $3,684 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,667 | $56 |
| New patient visit (30+ min) | 58 | $3,032 | $52 |
| External shock to heart to regulate heart beat | 32 | $2,914 | $88 |
| Programming of multiple lead implantable defibrillator system | 30 | $2,228 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 200 | $1,944 | $6 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,582 | $79 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 31 | $1,530 | $41 |
| Programming of dual lead pacemaker system | 26 | $1,457 | $36 |
| Programming of multiple lead implantable defibrillator system | 20 | $1,034 | $49 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator at time of implantation or replacement | 13 | $1,029 | $79 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $1,007 | $44 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 42 | $871 | $19 |
| Hospital observation care on day of discharge | 17 | $851 | $50 |
| Programming of dual lead implantable defibrillator system | 12 | $751 | $50 |
| Programming of dual lead pacemaker system | 21 | $616 | $28 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $583 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $547 | $30 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 14 | $372 | $25 |
| Short return visit | 14 | $319 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $146 | $10 |
2014: 36 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 64 | $56,968 | $890 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 80 | $25,969 | $313 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 57 | $19,150 | $336 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 47 | $16,449 | $336 |
| Insertion of implantable defibrillator system | 21 | $14,602 | $695 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 18 | $12,730 | $670 |
| Return visit (30+ min) | 139 | $12,131 | $57 |
| Programming of heart rhythm stimulation after drug infusion | 85 | $11,361 | $128 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 70 | $10,051 | $138 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 74 | $8,954 | $115 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $5,886 | $392 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 11 | $4,081 | $371 |
| External shock to heart to regulate heart beat | 33 | $3,753 | $96 |
| New patient visit (60+ min) | 25 | $2,746 | $110 |
| Programming of multiple lead implantable defibrillator system | 23 | $2,331 | $69 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 14 | $2,023 | $145 |
| New patient visit (30+ min) | 35 | $1,985 | $57 |
| Programming of dual lead implantable defibrillator system | 22 | $1,782 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 183 | $1,675 | $6 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 16 | $1,594 | $94 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 27 | $1,320 | $44 |
| Programming of dual lead pacemaker system | 21 | $1,227 | $42 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,185 | $56 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $1,151 | $50 |
| Short return visit (20+ min) | 28 | $1,126 | $39 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,114 | $80 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator at time of implantation or replacement | 12 | $1,064 | $89 |
| Follow-up observation care per day, typically 15 minutes | 32 | $1,001 | $31 |
| Return visit (30+ min) | 14 | $896 | $60 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 26 | $721 | $27 |
| Hospital observation care on day of discharge | 12 | $680 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $645 | $31 |
| Injection for x-ray imaging procedure into vein of arm or leg | 24 | $515 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 29 | $497 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 14 | $345 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $272 | $12 |
2013: 33 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 74 | $65,005 | $855 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 73 | $24,007 | $320 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 72 | $23,722 | $321 |
| Return visit (30+ min) | 131 | $15,104 | $74 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 44 | $14,100 | $300 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $8,953 | $639 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 75 | $8,357 | $106 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $5,331 | $355 |
| Programming of heart rhythm stimulation after drug infusion | 35 | $4,525 | $122 |
| Short return visit | 73 | $4,330 | $33 |
| Insertion of catheters for recording and pacing of left lower heart chamber rhythm and induction of abnormal rhythm | 31 | $4,248 | $133 |
| New patient visit (60+ min) | 30 | $3,873 | $129 |
| Programming of dual lead implantable defibrillator system | 43 | $3,692 | $44 |
| Programming of multiple lead implantable defibrillator system | 36 | $3,323 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 149 | $2,976 | $13 |
| Return visit (30+ min) | 45 | $2,816 | $59 |
| Programming of dual lead pacemaker system | 50 | $2,563 | $36 |
| External shock to heart to regulate heart beat | 25 | $2,525 | $94 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 11 | $1,910 | $174 |
| New patient visit (45+ min) | 13 | $1,664 | $128 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,492 | $83 |
| Short return visit (20+ min) | 22 | $1,374 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,272 | $79 |
| New patient visit (30+ min) | 12 | $1,007 | $84 |
| Follow-up observation care per day, typically 15 minutes | 32 | $987 | $30 |
| Short return visit (20+ min) | 24 | $911 | $36 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 43 | $866 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $852 | $53 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 11 | $636 | $49 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $609 | $38 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 15 | $431 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 57 | $408 | $6 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $394 | $26 |
Medicaid work
$1,296 in 2024
Medicaid paid $1,296 for 24 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 24 | $1,296 |
| 2024 | 24 | 1 | 17 | $1,296 |
| 2023 | 12 | 1 | 12 | $257 |
| 2022 | 27 | 2 | 14 | $940 |
| 2021 | 40 | 1 | 14 | $458 |
| 2018 | 14 | 1 | 13 | $199 |
See the largest Medicaid services in earlier years
2023
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 12 | $257 |
2022
| Return visit (30+ min) | 13 | $763 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 14 | $177 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 40 | $458 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 14 | $199 |
Drugs they prescribed that Part D paid
$160,072
Pharmacies billed $160,072 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
438 generic and 135 brand-name prescriptions · $160,072 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 70 | $79,176 | $1,131 |
| Xarelto | 46 | $50,172 | $1,091 |
| Flecainide Acetate | 98 | $3,728 | $38 |
| Verapamil Er | 16 | $685 | $43 |
| Metoprolol | 26 | $527 | $20 |
See all 15 drugs
| Eliquis | 70 | $79,176 | $1,131 |
| Xarelto | 46 | $50,172 | $1,091 |
| Flecainide Acetate | 98 | $3,728 | $38 |
| Verapamil Er | 16 | $685 | $43 |
| Metoprolol | 26 | $527 | $20 |
| Sotalol | 21 | $433 | $21 |
| Spironolactone | 11 | $292 | $27 |
| Carvedilol | 23 | $290 | $13 |
| Metoprolol | 21 | $144 | $7 |
| Amlodipine Besylate | 18 | $141 | $8 |
| Atenolol | 28 | $126 | $4 |
| Pantoprazole | 17 | $122 | $7 |
| Furosemide | 18 | $79 | $4 |
| Losartan | 13 | $68 | $5 |
| Lisinopril | 13 | $59 | $5 |
Year by year
| 2024 | 573 | 152 | None | 24% | $160,072 |
| 2023 | 471 | 144 | None | 27% | $159,301 |
| 2022 | 542 | 147 | 0% (0) | 33% | $190,724 |
| 2021 | 519 | 137 | 0% (0) | 35% | $139,187 |
| 2020 | 403 | 117 | 0% (0) | 31% | $89,089 |
| 2019 | 488 | 119 | 0% (0) | 29% | $86,416 |
| 2018 | 303 | 76 | None | 19% | $36,231 |
| 2017 | 294 | 93 | None | 30% | $42,640 |
| 2016 | 1,272 | 189 | None | 36% | $182,170 |
| 2015 | 1,129 | 172 | None | 30% | $137,038 |
| 2014 | 741 | 123 | None | 28% | $92,620 |
| 2013 | 756 | 136 | 2% (14) | 24% | $71,423 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Eliquis | 53 | $71,158 | $1,343 |
| Xarelto | 49 | $62,419 | $1,274 |
| Flecainide Acetate | 55 | $2,600 | $47 |
| Sotalol | 11 | $591 | $54 |
| Metoprolol | 19 | $315 | $17 |
| Amlodipine Besylate | 19 | $187 | $10 |
| Amiodarone | 13 | $163 | $13 |
| Pantoprazole | 21 | $150 | $7 |
| Metoprolol | 23 | $140 | $6 |
| Losartan | 12 | $108 | $9 |
| Carvedilol | 14 | $92 | $7 |
| Spironolactone | 11 | $91 | $8 |
| Atenolol | 13 | $64 | $5 |
| Clopidogrel | 11 | $47 | $4 |
2022: 14 drugs
| Xarelto | 86 | $83,580 | $972 |
| Eliquis | 68 | $73,367 | $1,079 |
| Flecainide Acetate | 49 | $3,120 | $64 |
| Diltiazem 24hr Er (Cd) | 30 | $721 | $24 |
| Sotalol | 17 | $629 | $37 |
| Amiodarone | 20 | $413 | $21 |
| Metoprolol | 22 | $361 | $16 |
| Metoprolol | 28 | $297 | $11 |
| Pantoprazole | 16 | $121 | $8 |
| Lisinopril | 11 | $113 | $10 |
| Losartan | 15 | $97 | $6 |
| Furosemide | 11 | $82 | $7 |
| Atenolol | 21 | $71 | $3 |
| Amlodipine Besylate | 12 | $58 | $5 |
2021: 11 drugs
| Eliquis | 77 | $61,980 | $805 |
| Xarelto | 82 | $61,065 | $745 |
| Flecainide Acetate | 61 | $4,804 | $79 |
| Diltiazem 24hr Er (Cd) | 20 | $827 | $41 |
| Sotalol | 29 | $796 | $27 |
| Metoprolol | 25 | $480 | $19 |
| Losartan | 24 | $477 | $20 |
| Digoxin | 16 | $385 | $24 |
| Metoprolol | 20 | $139 | $7 |
| Atenolol | 21 | $120 | $6 |
| Lisinopril | 14 | $66 | $5 |
2020: 10 drugs
| Xarelto | 50 | $39,701 | $794 |
| Eliquis | 58 | $38,229 | $659 |
| Flecainide Acetate | 56 | $4,016 | $72 |
| Sotalol | 27 | $823 | $30 |
| Atenolol | 20 | $258 | $13 |
| Amiodarone | 12 | $207 | $17 |
| Carvedilol | 12 | $144 | $12 |
| Metoprolol | 16 | $118 | $7 |
| Losartan | 12 | $110 | $9 |
| Lisinopril | 11 | $82 | $7 |
2019: 15 drugs
| Eliquis | 58 | $39,234 | $676 |
| Xarelto | 59 | $35,874 | $608 |
| Flecainide Acetate | 59 | $3,853 | $65 |
| Sotalol | 46 | $1,369 | $30 |
| Propafenone | 12 | $601 | $50 |
| Metoprolol | 20 | $372 | $19 |
| Digox | 11 | $295 | $27 |
| Diltiazem 24hr Er | 14 | $291 | $21 |
| Potassium Chloride | 14 | $270 | $19 |
| Lisinopril | 18 | $231 | $13 |
| Amiodarone | 11 | $155 | $14 |
| Furosemide | 20 | $108 | $5 |
| Metoprolol | 18 | $108 | $6 |
| Losartan | 15 | $83 | $6 |
| Atenolol | 13 | $75 | $6 |
2018: 8 drugs
| Eliquis | 24 | $14,795 | $616 |
| Xarelto | 27 | $12,985 | $481 |
| Flecainide Acetate | 36 | $3,684 | $102 |
| Sotalol | 39 | $608 | $16 |
| Losartan | 19 | $134 | $7 |
| Metoprolol | 17 | $122 | $7 |
| Clopidogrel | 11 | $83 | $8 |
| Carvedilol | 11 | $74 | $7 |
2017: 8 drugs
| Xarelto | 56 | $24,204 | $432 |
| Eliquis | 17 | $6,688 | $393 |
| Flecainide Acetate | 24 | $3,686 | $154 |
| Sotalol | 11 | $169 | $15 |
| Carvedilol | 13 | $160 | $12 |
| Clopidogrel | 15 | $154 | $10 |
| Metoprolol | 14 | $150 | $11 |
| Lisinopril | 14 | $67 | $5 |
2016: 25 drugs
| Xarelto | 232 | $101,013 | $435 |
| Eliquis | 91 | $37,303 | $410 |
| Tikosyn | 14 | $6,372 | $455 |
| Flecainide Acetate | 66 | $3,697 | $56 |
| Mexiletine | 12 | $1,839 | $153 |
| Diltiazem 24hr Er | 32 | $1,834 | $57 |
| Sotalol | 81 | $1,617 | $20 |
| Metoprolol | 25 | $747 | $30 |
| Clopidogrel | 29 | $613 | $21 |
| Lisinopril | 90 | $584 | $6 |
| Cartia Xt | 18 | $575 | $32 |
| Amiodarone | 33 | $546 | $17 |
| Atorvastatin | 22 | $505 | $23 |
| Potassium Chloride | 20 | $502 | $25 |
| Propafenone | 16 | $470 | $29 |
| Furosemide | 70 | $439 | $6 |
| Carvedilol | 39 | $383 | $10 |
| Diltiazem | 17 | $317 | $19 |
| Amlodipine Besylate | 18 | $270 | $15 |
| Verapamil Er | 15 | $192 | $13 |
| Losartan | 33 | $188 | $6 |
| Atenolol | 20 | $168 | $8 |
| Spironolactone | 19 | $151 | $8 |
| Metoprolol | 23 | $135 | $6 |
| Hydrochlorothiazide | 16 | $81 | $5 |
2015: 27 drugs
| Xarelto | 171 | $77,652 | $454 |
| Eliquis | 56 | $22,468 | $401 |
| Flecainide Acetate | 59 | $3,287 | $56 |
| Crestor | 12 | $2,992 | $249 |
| Klor-Con M20 | 13 | $1,470 | $113 |
| Sotalol | 101 | $1,420 | $14 |
| Amiodarone | 31 | $983 | $32 |
| Losartan | 42 | $838 | $20 |
| Potassium Chloride | 23 | $700 | $30 |
| Metoprolol | 17 | $685 | $40 |
| Cartia Xt | 25 | $662 | $26 |
| Warfarin | 30 | $524 | $17 |
| Diltiazem 24hr Er | 14 | $509 | $36 |
| Carvedilol | 37 | $474 | $13 |
| Lisinopril | 61 | $439 | $7 |
| Propafenone | 15 | $430 | $29 |
| Clopidogrel | 23 | $314 | $14 |
| Atenolol | 20 | $293 | $15 |
| Furosemide | 55 | $288 | $5 |
| Amlodipine Besylate | 34 | $269 | $8 |
| Diltiazem | 12 | $238 | $20 |
| Metoprolol | 25 | $213 | $9 |
| Nadolol | 12 | $205 | $17 |
| Nitrostat | 11 | $185 | $17 |
| Sotalol Af | 11 | $138 | $13 |
| Simvastatin | 14 | $125 | $9 |
| Verapamil Er | 13 | $91 | $7 |
2014: 20 drugs
| Xarelto | 131 | $56,133 | $428 |
| Eliquis | 39 | $17,553 | $450 |
| Klor-Con M20 | 20 | $2,362 | $118 |
| Flecainide Acetate | 41 | $1,883 | $46 |
| Sotalol | 44 | $1,068 | $24 |
| Propafenone | 16 | $1,025 | $64 |
| Amiodarone | 26 | $850 | $33 |
| Potassium Chloride | 14 | $819 | $58 |
| Clopidogrel | 12 | $608 | $51 |
| Diltiazem 24hr Er | 18 | $570 | $32 |
| Digox | 12 | $490 | $41 |
| Atenolol | 31 | $336 | $11 |
| Warfarin | 34 | $327 | $10 |
| Carvedilol | 19 | $309 | $16 |
| Lisinopril | 35 | $305 | $9 |
| Spironolactone | 16 | $305 | $19 |
| Amlodipine Besylate | 20 | $213 | $11 |
| Furosemide | 28 | $174 | $6 |
| Losartan | 15 | $146 | $10 |
| Metoprolol | 12 | $100 | $8 |
2013: 23 drugs
| Xarelto | 80 | $31,161 | $390 |
| Eliquis | 27 | $8,297 | $307 |
| Pradaxa | 13 | $5,222 | $402 |
| Amiodarone | 40 | $2,298 | $57 |
| Lovaza | 13 | $1,837 | $141 |
| Propafenone | 21 | $1,614 | $77 |
| Sotalol | 54 | $1,482 | $27 |
| Flecainide Acetate | 28 | $1,224 | $44 |
| Cartia Xt | 17 | $1,020 | $60 |
| Clopidogrel | 14 | $841 | $60 |
| Atorvastatin | 16 | $668 | $42 |
| Metoprolol | 15 | $643 | $43 |
| Amlodipine Besylate | 41 | $455 | $11 |
| Carvedilol | 21 | $343 | $16 |
| Atenolol | 23 | $314 | $14 |
| Lisinopril | 29 | $305 | $11 |
| Ramipril | 11 | $257 | $23 |
| Simvastatin | 14 | $236 | $17 |
| Warfarin | 25 | $218 | $9 |
| Furosemide | 29 | $203 | $7 |
| Metoprolol | 25 | $121 | $5 |
| Levothyroxine | 12 | $97 | $8 |
| Alprazolam | 12 | $77 | $6 |
Money from drug and device companies
$276,868 in 2025
| 2025 | 15 | 177 | $238,726 | $276,868 |
| 2024 | 16 | 131 | $158,151 | $180,982 |
| 2023 | 15 | 216 | $124,213 | $153,892 |
| 2022 | 16 | 111 | $59,300 | $75,884 |
| 2021 | 14 | 98 | $93,200 | $97,613 |
| 2020 | 11 | 87 | $143,250 | $147,066 |
| 2019 | 20 | 192 | $145,925 | $213,055 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Farapulse | $190,701 | 127 payments
|
| Synaptic Medical | None | $81,481 | 6 payments
|
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $2,114 | 3 payments
|
| Abbott Laboratories | Ensite | $638 | 6 payments
|
| Medtronic | Affera Mapping System | $501 | 4 payments
|
| Biosense Webster | Carto 3 | $409 | 7 payments
|
See all 175 published payments
| Boston Scientific | Paid to speak or teach · 2025-12-31 | General - Ep | $625 |
| Boston Scientific | Paid to speak or teach · 2025-12-31 | General - Ep | $4,375 |
| Abbott Laboratories | Meals · 2025-12-24 | Ensite | $78 |
| Boston Scientific | Paid to speak or teach · 2025-12-18 | General - Ep | $1,250 |
| Boston Scientific | Paid to speak or teach · 2025-12-18 | General - Ep | $6,250 |
| Boston Scientific | Meals · 2025-12-16 | Farapulse | $32 |
| Cordis US | Meals · 2025-12-02 | Mynx Control Venous | $16 |
| Vektor Medical | Meals · 2025-12-02 | Vmap | $170 |
| Boston Scientific | Paid to speak or teach · 2025-11-28 | General - Ep | $1,250 |
| Boston Scientific | Paid to speak or teach · 2025-11-28 | General - Ep | $6,250 |
| Boston Scientific | Paid to speak or teach · 2025-11-28 | General - Ep | $1,250 |
| Boston Scientific | Paid to speak or teach · 2025-11-28 | General - Ep | $3,750 |
| Boston Scientific | Paid to speak or teach · 2025-11-28 | General - Ep | $1,250 |
| Boston Scientific | Paid to speak or teach · 2025-11-28 | General - Ep | $5,000 |
| Boston Scientific | Paid to speak or teach · 2025-11-28 | General - Ep | $625 |
| Boston Scientific | Paid to speak or teach · 2025-11-20 | Farapulse | $625 |
| Boston Scientific | Paid to speak or teach · 2025-11-20 | Farapulse | $10,000 |
| Boston Scientific | Paid to speak or teach · 2025-11-20 | Farapulse | $625 |
| Boston Scientific | Meals · 2025-11-18 | Emblem Mri S-Icd | $8 |
| Boston Scientific | Paid to speak or teach · 2025-11-13 | General - Therapies | $1,875 |
| Boston Scientific | Meals · 2025-11-12 | Farapulse | $21 |
| Medtronic | Meals · 2025-11-12 | Affera Mapping System | $164 |
| Medtronic | Meals · 2025-11-12 | Affera Mapping System | $32 |
| Cordis US | Meals · 2025-11-07 | Mynx Control Venous | $17 |
| Boston Scientific | Paid to speak or teach · 2025-11-06 | General - Ep | $1,875 |
| Boston Scientific | Paid to speak or teach · 2025-11-06 | General - Ep | $5,625 |
| Synaptic Medical | Meals · 2025-11-05 | None | $100 |
| Synaptic Medical | Consulting · 2025-11-04 | None | $32,376 |
| Biosense Webster | Meals · 2025-10-31 | Carto 3 | $130 |
| Biosense Webster | Meals · 2025-10-30 | Carto 3 | $42 |
| Cordis US | Meals · 2025-10-29 | Mynx Control Venous | $3 |
| Cordis US | Meals · 2025-10-29 | Mynx Control Venous | $5 |
| Boston Scientific | Meals · 2025-10-22 | Latitude Communicator Power Supply | $20 |
| Cordis US | Meals · 2025-10-22 | Mynx Control Venous | $2 |
| Boston Scientific | Paid to speak or teach · 2025-10-16 | Farapulse | $3,750 |
| Boston Scientific | Paid to speak or teach · 2025-10-16 | Farapulse | $625 |
| Boston Scientific | Paid to speak or teach · 2025-10-16 | Farapulse | $1,250 |
| Boston Scientific | Meals · 2025-10-16 | Farapulse | $48 |
| Boston Scientific | Travel · 2025-10-16 | Farapulse | $12 |
| Boston Scientific | Paid to speak or teach · 2025-10-16 | Farapulse | $3,250 |
| Boston Scientific | Paid to speak or teach · 2025-10-16 | Farapulse | $625 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | General - Ep | $1,875 |
| Boston Scientific | Paid to speak or teach · 2025-10-09 | General - Ep | $4,375 |
| Boston Scientific | Meals · 2025-10-05 | Farapulse | $104 |
| Boston Scientific | Meals · 2025-10-04 | Farapulse | $455 |
| Boston Scientific | Meals · 2025-10-03 | Farapulse | $550 |
| Boston Scientific | Meals · 2025-10-02 | Rhythmia Mapping System | $197 |
| Boston Scientific | Meals · 2025-10-02 | Farapulse | $10 |
| Boston Scientific | Meals · 2025-10-01 | Rhythmia Mapping System | $90 |
| Exact Sciences | Meals · 2025-09-29 | None | $15 |
| Boston Scientific | Meals · 2025-09-25 | Rhythmia Mapping System | $13 |
| Cordis US | Meals · 2025-09-24 | Mynx Control Venous | $2 |
| Boston Scientific | Meals · 2025-09-23 | Farapulse | $33 |
| Boston Scientific | Meals · 2025-09-23 | Farapulse | $13 |
| Boston Scientific | Travel · 2025-09-22 | Farapulse | $210 |
| Boston Scientific | Travel · 2025-09-22 | Farapulse | $582 |
| Boston Scientific | Meals · 2025-09-19 | Farapulse | $46 |
| Abbott Laboratories | Meals · 2025-09-10 | Ensite | $18 |
| Medtronic | Meals · 2025-09-09 | Affera Mapping System | $217 |
| Novartis Pharmaceuticals | Meals · 2025-08-28 | Leqvio | $20 |
| Synaptic Medical | Consulting · 2025-08-28 | None | $3,500 |
| Boston Scientific | Meals · 2025-08-22 | General - Ep | $38 |
| Boston Scientific | Meals · 2025-08-16 | Rhythmia Mapping System | $132 |
| Boston Scientific | Consulting · 2025-08-14 | General - Therapies | $313 |
| Boston Scientific | Consulting · 2025-08-14 | Farapulse | $625 |
| Boston Scientific | Consulting · 2025-08-14 | Farapulse | $5,000 |
| Boston Scientific | Travel · 2025-08-14 | Farapulse | $260 |
| Boston Scientific | Meals · 2025-08-14 | Farapulse | $56 |
| Boston Scientific | Travel · 2025-08-14 | Farapulse | $31 |
| Boston Scientific | Meals · 2025-08-13 | Watchman Flx | $143 |
| Biosense Webster | Meals · 2025-08-12 | None | $44 |
| Abbott Laboratories | Meals · 2025-08-11 | Ensite | $109 |
| Actelion Pharmaceuticals US | Meals · 2025-08-04 | Opsynvi | $34 |
| Synaptic Medical | Consulting · 2025-08-01 | None | $39,225 |
| Boston Scientific | Meals · 2025-07-24 | General - Therapies | $146 |
| Boston Scientific | Paid to speak or teach · 2025-07-24 | Farapulse | $3,250 |
| Boston Scientific | Paid to speak or teach · 2025-07-24 | Farapulse | $625 |
| Synaptic Medical | Meals · 2025-07-23 | None | $30 |
| Boston Scientific | Meals · 2025-07-16 | Farapulse | $7 |
| Boston Scientific | Meals · 2025-07-16 | Farapulse | $31 |
| Boston Scientific | Meals · 2025-07-16 | Farapulse | $11 |
| Boston Scientific | Travel · 2025-07-14 | Farapulse | $273 |
| Cordis US | Meals · 2025-07-11 | Mynx Control Venous | $23 |
| Biosense Webster | Meals · 2025-07-07 | Carto 3 | $41 |
| Synaptic Medical | Consulting · 2025-07-07 | None | $6,250 |
| Boston Scientific | Paid to speak or teach · 2025-07-03 | Clinical Trial Product | $625 |
| Boston Scientific | Paid to speak or teach · 2025-07-03 | Clinical Trial Product | $3,750 |
| Boston Scientific | Travel · 2025-07-03 | Clinical Trial Product | $47 |
| Verona Pharma | Meals · 2025-06-30 | Ohtuvayre | $27 |
| Cordis US | Meals · 2025-06-23 | Mynx Control Venous | $134 |
| Boston Scientific | Meals · 2025-06-13 | Emblem Mri S-Icd | $34 |
| Boston Scientific | Meals · 2025-06-13 | Emblem Mri S-Icd | $66 |
| Boston Scientific | Travel · 2025-06-13 | Emblem Mri S-Icd | $222 |
| Boston Scientific | Travel · 2025-06-12 | Emblem Mri S-Icd | $263 |
| Boston Scientific | Travel · 2025-06-12 | Emblem Mri S-Icd | $178 |
| Boston Scientific | Travel · 2025-06-12 | Emblem Mri S-Icd | $286 |
| Biosense Webster | Meals · 2025-06-11 | Carto 3 | $53 |
| Impulse Dynamics (USA) | Meals · 2025-06-11 | Optimizer | $158 |
| Cordis US | Meals · 2025-06-06 | Mynx Control Venous | $1 |
| Medtronic | Meals · 2025-06-04 | Affera Mapping System | $89 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $147 |
| Cordis US | Meals · 2025-05-20 | Mynx Control Venous | $2 |
| Volta Medical | Meals · 2025-05-02 | Vx1 | $180 |
| Boston Scientific | Paid to speak or teach · 2025-05-01 | Farapulse | $3,250 |
| Boston Scientific | Paid to speak or teach · 2025-05-01 | Farapulse | $1,250 |
| Abbott Laboratories | Meals · 2025-05-01 | Ensite | $171 |
| AltaThera Pharmaceuticals | Consulting · 2025-04-29 | Sotalol Hydrochloride | $1,875 |
| Boston Scientific | Meals · 2025-04-28 | General - Therapies | $49 |
| Boston Scientific | Meals · 2025-04-27 | Farapulse | $94 |
| AltaThera Pharmaceuticals | Travel · 2025-04-27 | Sotalol Hydrochloride | $17 |
| AltaThera Pharmaceuticals | Meals · 2025-04-27 | Sotalol Hydrochloride | $222 |
| Biosense Webster | Meals · 2025-04-24 | Carto 3 | $94 |
| Boston Scientific | Consulting · 2025-04-24 | Farapulse | $938 |
| Boston Scientific | Paid to speak or teach · 2025-04-24 | Farapulse | $3,250 |
| Boston Scientific | Paid to speak or teach · 2025-04-24 | Farapulse | $625 |
| Boston Scientific | Meals · 2025-04-24 | General - Therapies | $75 |
| Cordis US | Meals · 2025-04-24 | Mynx Control Venous | $11 |
| Cordis US | Meals · 2025-04-15 | Mynx Control Venous | $3 |
| Boston Scientific | Consulting · 2025-04-10 | General - Therapies | $6,875 |
| Boston Scientific | Meals · 2025-04-10 | General - Therapies | $25 |
| Boston Scientific | Travel · 2025-04-10 | General - Therapies | $99 |
| Boston Scientific | Paid to speak or teach · 2025-04-10 | Farapulse | $5,000 |
| Boston Scientific | Travel · 2025-04-10 | Farapulse | $1,197 |
| Boston Scientific | Paid to speak or teach · 2025-04-10 | Farapulse | $16,875 |
| Cordis US | Meals · 2025-04-10 | Mynx Control Venous | $3 |
| Boston Scientific | Paid to speak or teach · 2025-04-03 | Farapulse | $625 |
| Boston Scientific | Paid to speak or teach · 2025-04-03 | Farapulse | $5,000 |
| Cordis US | Meals · 2025-03-28 | Mynx Control Venous | $22 |
| Boston Scientific | Travel · 2025-03-21 | General - Therapies | $245 |
| Boston Scientific | Travel · 2025-03-21 | Farapulse | $231 |
| Boston Scientific | Travel · 2025-03-21 | Farapulse | $91 |
| Boston Scientific | Meals · 2025-03-20 | General - Therapies | $5 |
| Boston Scientific | Travel · 2025-03-20 | General - Therapies | $267 |
| Boston Scientific | Travel · 2025-03-20 | General - Therapies | $174 |
| Abbott Laboratories | Meals · 2025-03-20 | Gallant | $113 |
| Boston Scientific | Meals · 2025-03-19 | General - Therapies | $108 |
| Boston Scientific | Travel · 2025-03-19 | General - Therapies | $52 |
| Boston Scientific | Travel · 2025-03-19 | General - Therapies | $267 |
| Boston Scientific | Travel · 2025-03-19 | General - Therapies | $307 |
| Boston Scientific | Meals · 2025-03-18 | General - Therapies | $39 |
| Boston Scientific | Travel · 2025-03-18 | General - Therapies | $52 |
| Boston Scientific | Travel · 2025-03-18 | General - Therapies | $127 |
| Boston Scientific | Travel · 2025-03-18 | General - Therapies | $292 |
| Boston Scientific | Meals · 2025-03-17 | General - Therapies | $88 |
| Boston Scientific | Travel · 2025-03-17 | General - Therapies | $85 |
| Boston Scientific | Travel · 2025-03-17 | General - Therapies | $125 |
| Boston Scientific | Travel · 2025-03-17 | General - Therapies | $215 |
| Boston Scientific | Travel · 2025-03-16 | General - Therapies | $161 |
| Boston Scientific | Travel · 2025-03-16 | General - Therapies | $123 |
| Boston Scientific | Travel · 2025-03-16 | General - Therapies | $117 |
| Boston Scientific | Meals · 2025-03-15 | General - Therapies | $111 |
| Boston Scientific | Travel · 2025-03-15 | General - Therapies | $11,198 |
| Boston Scientific | Travel · 2025-03-15 | General - Therapies | $11,198 |
| Boston Scientific | Meals · 2025-03-14 | General - Therapies | $246 |
| Boston Scientific | Travel · 2025-03-14 | General - Therapies | $224 |
| Boston Scientific | Travel · 2025-03-14 | General - Therapies | $284 |
| Boston Scientific | Meals · 2025-03-07 | Farapulse | $19 |
| Boston Scientific | Paid to speak or teach · 2025-03-06 | Farapulse | $5,000 |
| Boston Scientific | Travel · 2025-03-06 | Farapulse | $303 |
| Boston Scientific | Meals · 2025-03-06 | Farapulse | $104 |
| Boston Scientific | Paid to speak or teach · 2025-03-06 | Farapulse | $625 |
| Boston Scientific | Meals · 2025-02-26 | Rhythmia Mapping System | $120 |
| Boston Scientific | Travel · 2025-02-22 | Farapulse | $81 |
| Boston Scientific | Meals · 2025-02-21 | Farapulse | $143 |
| Boston Scientific | Travel · 2025-02-21 | Farapulse | $97 |
| Boston Scientific | Meals · 2025-02-21 | General - Ep | $113 |
| Boston Scientific | Travel · 2025-02-20 | Farapulse | $774 |
| Boston Scientific | Meals · 2025-02-06 | Farapulse | $132 |
| Elutia | Meals · 2025-01-29 | Ecm Patch,Pouch | $175 |
| Boston Scientific | Meals · 2025-01-23 | Farapulse | $537 |
| Boston Scientific | Paid to speak or teach · 2025-01-23 | Farapulse | $18,750 |
| Boston Scientific | Paid to speak or teach · 2025-01-23 | Farapulse | $5,000 |
| Boston Scientific | Travel · 2025-01-23 | Farapulse | $48 |
| Biosense Webster | Meals · 2025-01-13 | Carto 3 | $5 |
| Boston Scientific | Meals · 2025-01-10 | Farapulse | $92 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $180,982
| Synaptic Medical | None | $88,638 | 7 payments
|
| Boston Scientific | Versacross Access Solution | $83,794 | 90 payments
|
| Cortex | None | $6,172 | 2 payments
|
| Abbott Laboratories | Ensite | $1,097 | 10 payments
|
| Atricure | Atriclip Laa Exclusion System | $279 | 2 payments
|
| Biosense Webster | Carto 3 | $209 | 4 payments
|
| Medtronic | Pulseselect | $201 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer | $168 | 2 payments
|
| Circa Scientific | None | $122 | 1 payment
|
| Cordis US | Mynx Venous Vcd | $102 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $80 | 4 payments
|
| Philips North America | (Cm9) Amb Mon & Diag Und | $54 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Wainua | $17 | 1 payment
|
| Pfizer | Vyndaqel | $17 | 1 payment
|
| Lexicon Pharmaceuticals | None | $13 | 1 payment
|
2023: $153,892
| Boston Scientific | Rhythmia Mapping System | $87,083 | 119 payments
|
| Synaptic Medical | None | $37,124 | 8 payments
|
| Medtronic | Diamondtemp Bidirectional Ablation Catheter | $26,115 | 41 payments
|
| Abbott Laboratories | Ensite Precision | $1,718 | 19 payments
|
| Adagio Medical | None | $629 | 3 payments
|
| Biosense Webster | Carto 3 | $412 | 7 payments
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $207 | 5 payments
|
| Merit Medical Systems | None | $200 | 1 payment
|
| Atricure | Atriclip Laa Exclusion System | $136 | 4 payments
|
| Stereotaxis | Niobe | $115 | 2 payments
|
| Philips Electronics North America | (5091) Amb Mon & Diag Und | $50 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $30 | 1 payment
|
| Catheter Precision | None | $28 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $27 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $17 | 1 payment
|
2022: $75,884
| Medtronic | Arctic Front Advance | $36,159 | 33 payments
|
| Boston Scientific | Rhythmia Mapping System | $32,776 | 36 payments
|
| Impulse Dynamics (USA) | Optimizer | $3,374 | 3 payments
|
| Abbott Laboratories | Ensite Precision | $1,700 | 15 payments
|
| CardioFocus | Heartlight System | $866 | 6 payments
|
| Biosense Webster | Carto 3 | $430 | 5 payments
|
| Adagio Medical | Iclas Continuous Lesion Ablation System | $137 | 1 payment
|
| Philips Electronics North America | (5044) Mcot | $111 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $101 | 1 payment
|
| Sanofi-Aventis U.S. | None | $73 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $51 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $41 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $15 | 1 payment
|
| Pfizer | Eliquis | $13 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $13 | 1 payment
|
2021: $97,613
| Medtronic | Arctic Front | $75,920 | 45 payments
|
| Boston Scientific | General Therapies | $13,634 | 20 payments
|
| Stryker | N/A | $2,800 | 6 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $1,753 | 3 payments
|
| Acutus Medical | None | $1,727 | 3 payments
|
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $588 | 5 payments
|
| Baylis Medical Company | Clinical Trial Product | $425 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $200 | 6 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $198 | 3 payments
|
| Aziyo Biologics | Ecm Patch,Pouch | $182 | 1 payment
|
| ZOLL Respicardia | Remede System | $123 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $33 | 2 payments
|
| Impulse Dynamics (USA) | Optimizer Smart System | $20 | 1 payment
|
| Adagio Medical | Iclas Continuous Lesion Ablation System | $12 | 1 payment
|
2020: $147,066
| Medtronic Vascular | Arctic Front | $123,527 | 41 payments
|
| Boston Scientific | General - Therapies | $12,272 | 23 payments
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $5,469 | 10 payments
|
| Sanofi-Aventis U.S. | Multaq | $3,296 | 1 payment
|
| Baylis Medical Company | None | $2,058 | 4 payments
|
| Acutus Medical | None | $210 | 3 payments
|
| Impulse Dynamics (USA) | Optimizer Smart System | $107 | 1 payment
|
| Philips Electronics North America | (9210) Epd Solutions Und | $87 | 1 payment
|
| Aziyo Biologics | Ecm Patch,Pouch | $14 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $14 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $13 | 1 payment
|
2019: $213,055
| Medtronic Vascular | Arctic Front | $171,395 | 96 payments
|
| Boston Scientific | General Therapies | $15,513 | 34 payments
|
| Stryker | Reprocessed Ep Catheters | $10,822 | 10 payments
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax, Models | $6,001 | 8 payments
|
| Merit Medical Systems | None | $3,850 | 1 payment
|
| Abbott Laboratories | Ensite Cardiac Mapping System | $2,762 | 19 payments
|
| Baylis Medical Company | Nrg Needle | $1,685 | 1 payment
|
| Philips Electronics North America | Epd Kodex Procedure | $316 | 2 payments
|
| Biosense Webster | Carto 3 System | $276 | 5 payments
|
| HeartFlow | None | $168 | 2 payments
|
| Acutus Medical | None | $53 | 1 payment
|
| AngioDynamics | None | $42 | 1 payment
|
| iRhythm Technologies | Zio Patch | $38 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $26 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $25 | 2 payments
|
| Astellas Pharma US | Lexiscan | $25 | 1 payment
|
| Siemens Medical Solutions USA | Sc2000 | $18 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $16 | 1 payment
|
| Pfizer | Eliquis | $14 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $13 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Cortex, Inc. · Resolve-Af · 2024 | Their institution | $252,966 |
| Boston Scientific Corporation · Hemolysis After Pulsed Field Ablation, Characterizing the Dose Response · 2025 | Their institution | $120,000 |
| BOSTON SCIENTIFIC CORPORATION · Frozen Af · 2022 | Their institution | $114,424 |
| BOSTON SCIENTIFIC CORPORATION · Advent · 2022 | Their institution | $110,571 |
| Boston Scientific Corporation · Frozen Af · 2021 | Their institution | $103,290 |
| Ablacon, Inc. · Resolve-Af · 2023 | Their institution | $98,347 |
| Boston Scientific Corporation · Polarx Pas · 2025 | Their institution | $80,213 |
| Adagio Medical, Inc. · Iclas for Persistent Atrial Fibrillation · 2022 | Their institution | $76,625 |
| Medtronic, Inc. · Arrhythmia Service Line Assessment Pilot · 2023 | Their institution | $74,820 |
| Boston Scientific Corporation · Modular Atp · 2023 | Their institution | $67,895 |
| Medtronic Vascular, Inc. · Stop Persistent Af · 2019 | Their institution | $59,840 |
| Medtronic, Inc. · Investigator Sponsored Research · 2023 | Their institution | $52,364 |
| Boston Scientific Corporation · Resolve Af · 2025 | Their institution | $49,595 |
| Medtronic Vascular, Inc. · Stop Persistent Af · 2020 | Their institution | $48,459 |
| Boston Scientific Corporation · Advantage Af · 2023 | Their institution | $41,765 |
| Adagio Medical, Inc. · Iclas for Persistent Atrial Fibrillation · 2021 | Their institution | $39,803 |
| Boston Scientific Corporation · Modular Atp · 2024 | Their institution | $37,005 |
| Boston Scientific Corporation · Avant Guard · 2025 | Their institution | $34,523 |
| ATRICURE, INC. · 2024 | Their institution | $34,292 |
| Boston Scientific Corporation · Quantitative Analysis of Ablation Area By High-Density 3d Electroanatomic Mapping After Pulmonary Vein Isolation With A Size-Adjustable Cryoballoon System · 2024 | Their institution | $30,000 |
| ATRICURE, INC. · Outcome of Hybrid Ablation in Af Patients After Failed Pulmonary Vein Isolation · 2023 | Their institution | $26,754 |
| Boston Scientific Corporation · Avant Guard · 2024 | Their institution | $26,101 |
| Siemens Medical Solutions USA, Inc. · Assessment of the Feasibility of Volume Intracardiac Echocardiography Imaging During Catheter Cryoablation Procedures · 2020 | Their institution | $24,500 |
| Boston Scientific Corporation · Advent Lto · 2025 | Their institution | $24,373 |
| Boston Scientific Corporation · Polarx Pas · 2024 | Their institution | $23,570 |
| Boston Scientific Corporation · Advantage Af · 2024 | Their institution | $23,163 |
| Medtronic, Inc. · Investigator Sponsored Research · 2021 | Their institution | $22,729 |
| AtriCure, Inc. · Outcome of Hybrid Ablation in Af Patients After Failed Pulmonary Vein Isolation · 2025 | Their institution | $21,699 |
| Medtronic Vascular, Inc. · Investigator Sponsored Research · 2020 | Their institution | $21,623 |
| Boston Scientific Corporation · Frozen Af · 2023 | Their institution | $21,041 |
| Boston Scientific Corporation · Advent · 2021 | Their institution | $20,445 |
| Boston Scientific Corporation · Advent · 2023 | Their institution | $17,735 |
| Boston Scientific Corporation · Modular Atp · 2025 | Their institution | $16,929 |
| BOSTON SCIENTIFIC CORPORATION · Frozen Af · 2020 | Their institution | $15,575 |
| Boston Scientific Corporation · Frozen Af · 2024 | Their institution | $7,565 |
| Boston Scientific Corporation · Advantage Af · 2025 | Their institution | $7,370 |
| Siemens Medical Solutions USA, Inc. · Assessment of the Feasibility of Volume Echocardiography Images During Catheter Cryoablation Procedures. · 2020 | Their institution | $7,350 |
| Medtronic, Inc. · Investigator Sponsored Research · 2024 | Their institution | $6,738 |
| Siemens Medical Solutions USA, Inc. · Assessment of the Feasibility of Volume Intracardiac Echocardiography Imaging During Catheter Cryoablation Procedures. · 2020 | Their institution | $6,100 |
| Siemens Medical Solutions USA, Inc. · Assessment of the Feasibility of Volume Intracardiac Echocardiography During Catheter Cryoablation Procedures · 2019 | Their institution | $4,712 |
| Siemens Medical Solutions USA, Inc. · Software and Accessories · 2019 | Their institution | $4,712 |
| ATRICURE, INC. · Outcome of Hybrid Ablation in Af Patients After Failed Pulmonary Vein Isolation · 2024 | Their institution | $4,504 |
| Medtronic Vascular, Inc. · Investigator Sponsored Research · 2019 | Their institution | $2,509 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 88.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689618084
- Licence
- CA C150496California C150496: Current · expires 2026-11-30
- Trained
- Tufts University School of Medicine, 1997
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-06-15
- NPI last updated
- 2023-04-18
- NPI record certified
- 2023-04-18
This is when the NPI record was last certified, not a medical board exam.